Thermo Fisher Scientific Inc. (TMO) stock price, news and key stats

Price

Last close as of Sep 16, 2026. Delayed data; not a live quote.

Previous close

$641.39

Open

$642.00

Day range

$638.00 – $653.40

Volume

2.9M

About Thermo Fisher Scientific Inc.

Latest TMO news

• Analyzer makers focus on aluminum, precious metals
  Gold & Metals · Sep 16, 2026

  The increasing value of both precious and nonferrous metals is prompting analyzer manufacturers to enhance their focus on developing precision metal analyzing devices, particularly for recycling applications. As the global market for precious metals is projected to grow by over $95 billion, reaching $386.16 billion by 2030, the demand for accurate and efficient analysis tools is becoming more critical. This trend is driven by the rising prices of metals, which incentivizes recycling efforts and the need for precise measurement in recovery processes. Companies like Thermo Fisher Scientific are at the forefront of this shift, with their Niton XRF analyzers providing rapid and accurate assessments of metal content. Such advancements not only improve operational efficiency in recycling facilities but also support the broader sustainability goals within the industry. As the market for precious metals continues to expand, the implications for investors and stakeholders are significant, highlighting opportunities in both the technology and recycling sectors. The focus on precision analysis is likely to drive innovation and investment, further solidifying the role of these technologies in the evolving commodities landscape.

• The Target Report Annual Review—TTM August 2026 M&A Activity
  IPO & M&A · Sep 15, 2026

  The Target Report's annual review for the twelve months ending August 2026 highlights a significant uptick in mergers and acquisitions (M&A) activity, with total deal value reaching an unprecedented $2.5 trillion. This marks a 15% increase compared to the previous year, driven by a combination of favorable economic conditions, low-interest rates, and a surge in strategic consolidations across various sectors, particularly technology and healthcare. Notably, the technology sector accounted for nearly 40% of the total deal value, as companies sought to enhance their digital capabilities and expand their market reach amid ongoing digital transformation trends. Healthcare also saw robust activity, with several high-profile mergers aimed at streamlining operations and improving patient care through integrated services. The report indicates that private equity firms have played a crucial role in this M&A boom, with substantial capital raised for acquisitions, further fueling competition for targets. Market analysts suggest that this heightened M&A activity could lead to increased volatility in equity markets as companies reposition themselves for growth. Investors are advised to monitor sector-specific trends and the potential regulatory implications of large-scale consolidations, which may prompt scrutiny from antitrust authorities. Overall, the Target Report underscores a dynamic landscape where strategic acquisitions are likely to shape the future of various industries.

• Improved Neubauer Chamber Slides Market Outlook to 2035
  Market Outlook · Sep 9, 2026

  The Neubauer chamber slides market is projected to experience significant growth through 2035, driven by advancements in laboratory technology and an increasing demand for precise cell counting in various research and clinical applications. The rising prevalence of chronic diseases and the growing emphasis on early diagnosis are key factors contributing to this positive outlook. As healthcare providers and research institutions continue to prioritize accurate and efficient diagnostic tools, the Neubauer chamber slides are expected to remain a staple in laboratories worldwide. Market analysts anticipate that the introduction of innovative designs and materials will enhance the functionality and usability of Neubauer chamber slides, further boosting their adoption. Additionally, the expansion of biotechnology and pharmaceutical sectors, particularly in emerging markets, is likely to create new opportunities for manufacturers. As competition intensifies, companies may focus on product differentiation and strategic partnerships to capture a larger share of the market. Investors and stakeholders should monitor these trends closely, as the growth of the Neubauer chamber slides market could have broader implications for the laboratory equipment sector. Increased demand may lead to heightened investments in research and development, ultimately fostering technological advancements that benefit the healthcare industry as a whole.

• Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls
  Yahoo Finance · Sep 9, 2026

  Wall Street analysts have recently made significant moves in their coverage of key companies, with Uber Technologies receiving an initiation of coverage and Thermo Fisher Scientific receiving an upgrade. Uber's initiation comes as the company continues to expand its services beyond ride-hailing, including food delivery and freight logistics, positioning itself for potential growth in a post-pandemic economy. Analysts are optimistic about Uber's ability to capitalize on these trends, which could lead to increased market share and revenue growth. In contrast, Thermo Fisher has been upgraded, reflecting confidence in its robust portfolio of life sciences tools and diagnostics. The upgrade suggests that analysts expect the company to benefit from ongoing demand for its products and services, particularly in the healthcare sector, where innovation and research funding remain strong. This positive outlook could bolster investor sentiment and drive stock performance, especially as the company continues to navigate a competitive landscape. These analyst calls highlight the dynamic nature of the market, where investor sentiment can shift rapidly based on company performance and broader economic indicators. As both Uber and Thermo Fisher adapt to changing market conditions, their respective stock movements will be closely watched by investors seeking to capitalize on emerging trends in technology and healthcare.

• In the News: Muer Yang on Private Equity’s Medical Device Push
  Private Equity · Sep 8, 2026

  Muer Yang, a prominent figure in the private equity sector, has recently highlighted the growing interest of private equity firms in the medical device industry. This trend is largely driven by the sector's potential for high returns, bolstered by an aging population and increasing demand for innovative healthcare solutions. Yang noted that private equity investments in medical devices have surged, as firms seek to capitalize on advancements in technology and the ongoing shift towards minimally invasive procedures. The implications for the market are significant. As private equity firms inject capital into medical device companies, there is potential for accelerated innovation and development of new products. This influx of funding can enhance competition within the industry, leading to improved patient outcomes and potentially lowering costs in the long term. However, it also raises concerns about the sustainability of such investments, particularly if firms prioritize short-term gains over long-term viability. Yang emphasized the importance of strategic partnerships between private equity firms and medical device manufacturers to navigate regulatory challenges and market dynamics effectively. As this trend continues, stakeholders across the healthcare spectrum will need to monitor the evolving landscape, as the intersection of private equity and medical devices could reshape the future of healthcare delivery.

• AI will cure cancer in our lifetime, claims boss of UK chip giant
  BBC Business · Sep 8, 2026

  The development of artificial intelligence (AI) applications for cancer treatment has been significantly hampered by ongoing semiconductor shortages, according to the CEO of the UK's largest technology firm. This shortage has not only delayed the rollout of innovative AI-driven therapies but also raised concerns about the broader implications for the healthcare sector and technology market. The CEO emphasized that while AI holds great promise in revolutionizing cancer care, the lack of essential computing power is stalling progress. Market analysts are closely monitoring this situation, as the intersection of technology and healthcare continues to attract substantial investment. The chip shortage, which has affected various industries, is now revealing its impact on life-saving innovations. Investors may need to reassess their portfolios, particularly in tech and biotech sectors, as delays in AI advancements could lead to slower revenue growth for companies involved in cancer research and treatment development. As the demand for AI capabilities in healthcare continues to rise, the urgency to resolve the semiconductor supply chain issues becomes increasingly critical. Stakeholders are advocating for increased production capacity and diversification of supply sources to mitigate future disruptions. The resolution of these challenges will not only benefit the healthcare industry but also restore confidence in the tech sector's ability to deliver on its promises.

• These industries will lead hiring in the next decade, with just one sector accounting for more than a third of all new jobs
  Fortune · Sep 5, 2026

  The U.S. labor market is set to experience significant growth over the next decade, with an estimated 5.2 million new jobs expected to be created between 2024 and 2034. This expansion will elevate total employment from 170 million to approximately 175.2 million workers. Notably, the healthcare and social assistance sector is poised to lead this growth, contributing 2.2 million new jobs, which accounts for over a third of all new positions anticipated during this period. The robust expansion in the healthcare sector reflects ongoing demographic trends, including an aging population that will require increased medical services and support. As the demand for healthcare professionals rises, industries such as nursing, home health care, and mental health services are expected to see particularly strong hiring. This trend may also influence educational institutions and training programs, which will need to adapt to prepare a workforce equipped to meet these evolving needs. In addition to healthcare, other sectors such as technology, renewable energy, and professional services are also expected to contribute significantly to job growth. The implications for the labor market are profound, as companies in these industries may face increased competition for talent, potentially driving wages higher. Investors and policymakers will need to monitor these trends closely, as shifts in employment patterns can have far-reaching effects on economic stability and growth.

• Secondary Discharge Grates Market Outlook to 2035
  Market Outlook · Sep 5, 2026

  The secondary discharge grates market is projected to experience steady growth through 2035, driven by increasing demand across various industries, including wastewater treatment, mining, and construction. As environmental regulations tighten and the need for efficient waste management solutions rises, the adoption of advanced discharge grates is expected to accelerate. Market analysts forecast a compound annual growth rate (CAGR) of approximately 4.5% over the next decade, reflecting a robust expansion in both developed and emerging markets. Key players in the industry are focusing on innovation and sustainability, with many investing in research and development to enhance the performance and durability of their products. The integration of smart technologies, such as IoT-enabled monitoring systems, is anticipated to further boost market growth by improving operational efficiency and reducing maintenance costs. Additionally, the rising trend of urbanization and infrastructure development in developing regions is likely to create new opportunities for manufacturers. However, the market may face challenges, including fluctuating raw material prices and competition from alternative waste management solutions. Companies will need to navigate these hurdles while capitalizing on the growing emphasis on environmental sustainability. Overall, the secondary discharge grates market is poised for a positive trajectory, with significant implications for stakeholders across the supply chain.

• M&A Update: Is DME Still Attractive to Investors?
  IPO & M&A · Sep 4, 2026

  The durable medical equipment (DME) sector continues to draw attention from investors, despite recent fluctuations in the broader healthcare market. With an aging population and increasing demand for home healthcare solutions, DME companies are positioned to benefit from long-term growth trends. Recent mergers and acquisitions in the sector highlight ongoing interest, as firms seek to consolidate resources and expand their market reach. However, potential investors must navigate challenges such as regulatory scrutiny and reimbursement pressures that could impact profitability. The recent uptick in interest rates may also affect financing conditions for M&A deals, potentially slowing down transaction volumes. Analysts suggest that while the DME market remains attractive, investors should conduct thorough due diligence to assess individual company fundamentals and market positioning before committing capital. As the landscape evolves, strategic partnerships and innovative product offerings will likely play a crucial role in determining which companies emerge as leaders in the DME space.

• Global Venture Funding Jumps 122% In August As Streak Of Billion-Dollar Deals Continues
  Crunchbase News · Sep 3, 2026

  Global venture funding surged to $42 billion in August, marking a 122% increase compared to the same month last year, despite a 25% decline from July's $56 billion. This robust growth reflects a continued appetite for investment in startups, with over 1,500 companies receiving funding during the month. The data from Crunchbase highlights a persistent trend of billion-dollar deals, which have been a significant driver of this funding boom. The ongoing influx of capital into the venture space suggests that investors remain optimistic about the long-term potential of startups, even amid broader economic uncertainties. The record number of billion-dollar rounds in recent months indicates a strong confidence in high-growth sectors, particularly in technology and healthcare. However, the drop from July's figures may signal a potential cooling off as investors reassess valuations and market conditions. Overall, the venture capital landscape appears robust, with significant implications for startups seeking to capitalize on this momentum.

All 34 articles in the app →

Index membership

• S&P 500 · Health Care

Related Health Care stocks

• AAgilent Technologies
• ABBVAbbVie
• ABTAbbott Laboratories
• ALGNAlign Technology
• AMGNAmgen
• BAXBaxter International
• BDXBecton Dickinson
• BIIBBiogen